Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the rank-math domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/vhosts/maiwald-test.dev5.yoyaba.tech/httpdocs/wp-includes/functions.php on line 6114
Pharma And Life Sciences: Experts Provide Practical Guidance – Maiwald

Event

All events

Pharma and Life Sciences: Experts Provide Practical Guidance

On 15 March 2018, Marco Stief (Partner, Maiwald) welcomed over 50 invited guests to the first lawyers’ event dedicated to pharma and life sciences and held in Maiwald’s offices in the center of Munich.

In five interesting talks, guests were guided through upcoming changes and current developments in the fields of pharma and life sciences.

Matthias Görich (specialist pharmacist for drug information, Maiwald) gave a marvelously clear overview of statutory safeguards for drugs outside the sphere of patent law.

Heike Röder-Hitschke (attorney-at-law, licensed specialist for intellectual property law, Maiwald) followed up with a very informative and practice-oriented talk on the “Specific Mechanisms” that applies in cases of parallel imports. This part of the event was rounded off with a discussion where guests were given an opportunity to put questions to the speakers.

After some light refreshments, Sebastian Haase (attorney-at-law, Maiwald) reported on the impending practical implications of the General Data Protection Regulation (GDPR) for the pharma and life science industries. His talk also touched on developments relating to compliance issues.

In a clearly structured presentation, Susanna Heurung (attorney-at-law, licensed specialist for intellectual property law, Maiwald) explained current developments in trademark law relating to medicines. This section was followed by a lively discussion between speakers and participants.

Dr Regina Neuefeind (Partner, European Patent Attorney) explained the sometimes complex management of IP rights relating to biosimilars. Her interesting contribution was followed by an animated question-and-answer session.

Spring-like temperatures permitted hosts and guests to assemble afterwards on the roof terrace of Elisenhof where a lively exchange of views took place in a relaxed atmosphere accompanied by barbecue specialties and wine.

Some comments from the guests expressing their satisfaction, both with the selected topics as well as the speakers:

“Congratulations on the successful event and the excellent team.”

“Super event – both the informative as well as the informal parts. Already looking forward to the next update of this kind.”

“The Maiwald event was very informative and the convivial get-together afterwards very enjoyable.”

“In summary, lively discussions, great speakers and super atmosphere. Definitely calls for a repeat!”

The full program can be downloaded as PDF